Breaking News Instant updates and real-time market news.

EIGI

Endurance

$9.40 /

+3.585 (+61.65%)

05:13
11/03/20
11/03
05:13
11/03/20
05:13

Endurance downgraded to Neutral from Outperform at Credit Suisse

Credit Suisse analyst Stephen Ju downgraded Endurance International Group Holdings to Neutral from Outperform with a $9.50 price target after the company agreed to be acquired by Clearlake Capital Group for $9.50 per share in cash.

  • 05

    Nov

TODAY'S FREE FLY STORIES

Periodicals
Pfizer sees ability to deliver vaccine faster than expected, Bloomberg reports » 09:37
01/26/21
01/26
09:37
01/26/21
09:37
PFE

Pfizer

$37.28 /

+0.74 (+2.03%)

, BNTX

BioNTech

$110.62 /

+2.33 (+2.15%)

Pfizer (PFE) CEO Albert…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PFE Pfizer
$37.28 /

+0.74 (+2.03%)

BNTX BioNTech
$110.62 /

+2.33 (+2.15%)

PFE Pfizer
$37.28 /

+0.74 (+2.03%)

01/14/21 Morgan Stanley
80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley
01/14/21 Oppenheimer
Essa Pharma price target raised to $20 from $9 at Oppenheimer
01/05/21 Argus
Viatris initiated with a Hold at Argus
12/31/20 Ladenburg
UK study supports potential of Arcturus COVID vaccine candidate, says Ladenburg
BNTX BioNTech
$110.62 /

+2.33 (+2.15%)

01/14/21 Morgan Stanley
80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley
12/29/20 Citi
Arcturus selloff brings 'very good' buying opportunity, says Citi
12/22/20 Roth Capital
Translate Bio price target raised to $37 from $30 at Roth Capital
12/15/20 Jefferies
Jefferies starts Maravai at Buy, says 'more than just a COVID vaccine play'
PFE Pfizer
$37.28 /

+0.74 (+2.03%)

BNTX BioNTech
$110.62 /

+2.33 (+2.15%)

  • 23
    Jul
  • 06
    Feb
PFE Pfizer
$37.28 /

+0.74 (+2.03%)

BNTX BioNTech
$110.62 /

+2.33 (+2.15%)

PFE Pfizer
$37.28 /

+0.74 (+2.03%)

BNTX BioNTech
$110.62 /

+2.33 (+2.15%)

PFE Pfizer
$37.28 /

+0.74 (+2.03%)

BNTX BioNTech
$110.62 /

+2.33 (+2.15%)

Hot Stocks
CarParts.com up 15% after announcing launch of EV-focused shopping hub » 09:37
01/26/21
01/26
09:37
01/26/21
09:37
PRTS

CarParts.com

$13.62 /

+1.29 (+10.46%)

Shares of CarParts.com…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PRTS CarParts.com
$13.62 /

+1.29 (+10.46%)

PRTS CarParts.com
$13.62 /

+1.29 (+10.46%)

11/12/20 RBC Capital
RBC Capital starts CarParts.com at Outperform with $15 price target
11/12/20 RBC Capital
CarParts.com initiated with an Outperform at RBC Capital
09/09/20 Roth Capital
CarParts.com re-initiated with a Buy at Roth Capital
09/01/20
Fly Intel: Top five analyst initiations
PRTS CarParts.com
$13.62 /

+1.29 (+10.46%)

  • 14
    Aug
PRTS CarParts.com
$13.62 /

+1.29 (+10.46%)

PRTS CarParts.com
$13.62 /

+1.29 (+10.46%)

Upgrade
Euronet upgraded to Buy from Neutral at Citi » 09:35
01/26/21
01/26
09:35
01/26/21
09:35
EEFT

Euronet

$131.45 /

-7.72 (-5.55%)

Citi analyst Andrew…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EEFT Euronet
$131.45 /

-7.72 (-5.55%)

EEFT Euronet
$131.45 /

-7.72 (-5.55%)

01/19/21 DA Davidson
DA Davidson doesn't see Walmart adding Western Union to hurt Euronet materially
01/13/21 Truist
Euronet price target raised to $195 from $160 at Truist
12/18/20 Northland
Euronet price target raised to $150 from $125 at Northland
12/02/20 Stephens
Stephens upgrades ACI Worldwide to Overweight after Starboard urges sale
EEFT Euronet
$131.45 /

-7.72 (-5.55%)

Syndicate
Supreme Cannabis prices $20M overnight marketed public offering » 09:34
01/26/21
01/26
09:34
01/26/21
09:34
SPRWF

Supreme Cannabis

$0.00 /

+ (+0.00%)

The Supreme Cannabis…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SPRWF Supreme Cannabis
$0.00 /

+ (+0.00%)

SPRWF Supreme Cannabis
$0.00 /

+ (+0.00%)

07/22/20 Stifel
Supreme Cannabis re-initiated with a Hold at Stifel
07/07/20 Stifel
Stifel suspends coverage of cannabis names after analyst death
05/19/20 Stifel
Supreme Cannabis price target lowered to C$0.30 from C$0.50 at Stifel
05/19/20 CIBC
Supreme Cannabis price target lowered to C$0.35 from C$0.50 at CIBC
Recommendations
KalVista price target raised to $32 from $25 at Needham » 09:34
01/26/21
01/26
09:34
01/26/21
09:34
KALV

KalVista

$16.47 /

+0.41 (+2.55%)

Needham analyst Serge…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KALV KalVista
$16.47 /

+0.41 (+2.55%)

KALV KalVista
$16.47 /

+0.41 (+2.55%)

12/10/20 Roth Capital
Roth Capital 'very bullish' on KalVista HAE Phase 2 data readout
10/15/20 Roth Capital
KalVista updates highlight potential to become HAE leader, says Roth Capital
06/15/20
Fly Intel: Top five analyst initiations
06/15/20 H.C. Wainwright
KalVista initiated with a Buy at H.C. Wainwright
KALV KalVista
$16.47 /

+0.41 (+2.55%)

KALV KalVista
$16.47 /

+0.41 (+2.55%)

Conference/Events
Jefferies software/Internet analyst to hold analyst/industry conference call » 09:31
01/26/21
01/26
09:31
01/26/21
09:31

Software & Internet…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Hot Stocks
Johnson & Johnson says 'comfortable' meeting COVID-19 vaccine demand  09:30
01/26/21
01/26
09:30
01/26/21
09:30
JNJ

Johnson & Johnson

$165.91 /

+2.23 (+1.36%)

 
ShowHide Related Items >><<
JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

01/15/21 B. Riley Securities
Arcturus Therapeutics downgraded to Neutral from Buy at B. Riley Securities
01/14/21 Morgan Stanley
80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley
01/14/21 Oppenheimer
Essa Pharma price target raised to $20 from $9 at Oppenheimer
12/29/20 Piper Sandler
Piper still believes in Arcturus vaccine after 'underwhelming' immunogenicity
JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

Recommendations
Inter Parfums price target raised to $55 from $50 at DA Davidson » 09:29
01/26/21
01/26
09:29
01/26/21
09:29
IPAR

Inter Parfums

$60.50 /

+1.41 (+2.39%)

DA Davidson analyst Linda…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IPAR Inter Parfums
$60.50 /

+1.41 (+2.39%)

IPAR Inter Parfums
$60.50 /

+1.41 (+2.39%)

12/02/20 DA Davidson
Inter Parfums price target lowered to $50 from $55 at DA Davidson
11/11/20 DA Davidson
Inter Parfums price target raised to $55 from $39 at DA Davidson
11/11/20 Citi
Inter Parfums price target raised to $56 from $46 at Citi
08/12/20 BWS Financial
Inter Parfums upgraded to Buy from Neutral at BWS Financial
IPAR Inter Parfums
$60.50 /

+1.41 (+2.39%)

IPAR Inter Parfums
$60.50 /

+1.41 (+2.39%)

Recommendations
Manhattan Associates price target raised to $136 from $120 at Truist » 09:26
01/26/21
01/26
09:26
01/26/21
09:26
MANH

Manhattan Associates

$118.02 /

-0.17 (-0.14%)

Truist analyst Terry…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MANH Manhattan Associates
$118.02 /

-0.17 (-0.14%)

MANH Manhattan Associates
$118.02 /

-0.17 (-0.14%)

10/15/20 Truist
Manhattan Associates price target raised to $120 from $110 at Truist
07/06/20 Benchmark
Manhattan Associates price target raised to $105 from $83 at Benchmark
05/28/20 SunTrust
Manhattan Associates price target raised to $98 from $80 at SunTrust
05/21/20 SunTrust
Manhattan Associates price target raised to $80 from $70 at SunTrust
MANH Manhattan Associates
$118.02 /

-0.17 (-0.14%)

MANH Manhattan Associates
$118.02 /

-0.17 (-0.14%)

Upgrade
Canadian Pacific upgraded at Raymond James on improved traffic outlook » 09:26
01/26/21
01/26
09:26
01/26/21
09:26
CP

Canadian Pacific

$344.64 /

+5.17 (+1.52%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CP Canadian Pacific
$344.64 /

+5.17 (+1.52%)

CP Canadian Pacific
$344.64 /

+5.17 (+1.52%)

07:19 Today Raymond James
Canadian Pacific upgraded to Outperform from Market Perform at Raymond James
01/21/21 Scotiabank
Canadian National, Canadian Pacific cut at Scotiabank on valuation (yesterday)
01/20/21 Scotiabank
Canadian Pacific downgraded to Sector Perform from Outperform at Scotiabank
01/19/21 CIBC
Canadian Pacific price target raised to C$500 from C$490 at CIBC
CP Canadian Pacific
$344.64 /

+5.17 (+1.52%)

Downgrade
Valens downgraded to Underperform from Market Perform at Raymond James » 09:25
01/26/21
01/26
09:25
01/26/21
09:25
VLNCF

Valens Company

$0.00 /

+ (+0.00%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VLNCF Valens Company
$0.00 /

+ (+0.00%)

01/22/21 Desjardins
The Valens Company price target lowered to C$3.75 from C$4 at Desjardins
01/21/21 Stifel
The Valens Company price target lowered to C$3.25 from C$3.75 at Stifel
08/12/20 Raymond James
The Valens Company downgraded to Market Perform from Outperform at Raymond James
07/17/20 Canaccord
The Valens Company price target lowered to C$6 from C$6.50 at Canaccord
VLNCF Valens Company
$0.00 /

+ (+0.00%)

Upgrade
Canadian National upgraded at Raymond James on improved traffic outlook » 09:25
01/26/21
01/26
09:25
01/26/21
09:25
CNI

Canadian National

$107.98 /

+1.38 (+1.29%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CNI Canadian National
$107.98 /

+1.38 (+1.29%)

CNI Canadian National
$107.98 /

+1.38 (+1.29%)

07:20 Today Raymond James
Canadian National upgraded to Outperform from Market Perform at Raymond James
01/21/21 Scotiabank
Canadian National, Canadian Pacific cut at Scotiabank on valuation (yesterday)
01/20/21 Scotiabank
Canadian National downgraded to Sector Perform from Outperform at Scotiabank
01/13/21 Barclays
Canadian National upgraded to Equal Weight from Underweight at Barclays
CNI Canadian National
$107.98 /

+1.38 (+1.29%)

General news
U.S. FHFA home price index rose 1.0% to 310.1 in November » 09:25
01/26/21
01/26
09:25
01/26/21
09:25

U.S. FHFA home price…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

General news
Oil Action: WTI crude » 09:25
01/26/21
01/26
09:25
01/26/21
09:25

Oil Action: WTI crude…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Conference/Events
Yamana Gold to host conference call » 09:25
01/26/21
01/26
09:25
01/26/21
09:25
AUY

Yamana Gold

$5.15 /

-0.04 (-0.77%)

Management provides…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AUY Yamana Gold
$5.15 /

-0.04 (-0.77%)

AUY Yamana Gold
$5.15 /

-0.04 (-0.77%)

01/06/21 Barclays
Yamana Gold upgraded to Equal Weight from Underweight at Barclays
11/16/20 BMO Capital
Yamana Gold upgraded to Outperform from Market Perform at BMO Capital
11/04/20 Berenberg
Yamana Gold price target raised to 610 GBp from 590 GBp at Berenberg
10/22/20 National Bank
Yamana Gold price target lowered to C$9 from C$9.50 at National Bank
AUY Yamana Gold
$5.15 /

-0.04 (-0.77%)

AUY Yamana Gold
$5.15 /

-0.04 (-0.77%)

AUY Yamana Gold
$5.15 /

-0.04 (-0.77%)

Recommendations
Rhythm reported 'excellent results' from Phase 2 basket study, says Stifel » 09:24
01/26/21
01/26
09:24
01/26/21
09:24
RYTM

Rhythm Pharmaceuticals

$39.05 /

-0.44 (-1.11%)

Stifel analyst Derek…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RYTM Rhythm Pharmaceuticals
$39.05 /

-0.44 (-1.11%)

RYTM Rhythm Pharmaceuticals
$39.05 /

-0.44 (-1.11%)

01/05/21 Stifel
Rhythm Pharmaceuticals named a top pick, price target boosted to $36 at Stifel
11/30/20 Goldman Sachs
Goldman keeps Sell rating on Rhythm Pharmaceuticals after Imcivree approval
11/30/20 Ladenburg
Rhythm likely to sell Pediatric Review Voucher for $100M, says Ladenburg
11/30/20 BofA
Rhythm Pharmaceuticals downgraded to Neutral from Buy at BofA
RYTM Rhythm Pharmaceuticals
$39.05 /

-0.44 (-1.11%)

RYTM Rhythm Pharmaceuticals
$39.05 /

-0.44 (-1.11%)

Recommendations
Azek price target raised to $50 from $43 at RBC Capital » 09:23
01/26/21
01/26
09:23
01/26/21
09:23
AZEK

Azek

$42.44 /

+0.74 (+1.77%)

RBC Capital analyst Mike…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AZEK Azek
$42.44 /

+0.74 (+1.77%)

AZEK Azek
$42.44 /

+0.74 (+1.77%)

01/25/21 B. Riley Securities
Azek price target raised to $48 from $46 at B. Riley Securities
01/13/21 BMO Capital
Azek initiated with an Outperform at BMO Capital
12/31/20 William Blair
Azek, Trex among Blair's top Specialty Distribution ideas for 2021
12/04/20 DA Davidson
Azek price target raised to $39 from $33 at DA Davidson
AZEK Azek
$42.44 /

+0.74 (+1.77%)

  • 22
    Jan
  • 11
    Sep
  • 12
    Jun
AZEK Azek
$42.44 /

+0.74 (+1.77%)

AZEK Azek
$42.44 /

+0.74 (+1.77%)

AZEK Azek
$42.44 /

+0.74 (+1.77%)

Hot Stocks
Humana unit partners in Primary Care announces growth plans » 09:23
01/26/21
01/26
09:23
01/26/21
09:23
HUM

Humana

$403.97 /

-1.5 (-0.37%)

Partners in Primary Care…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HUM Humana
$403.97 /

-1.5 (-0.37%)

HUM Humana
$403.97 /

-1.5 (-0.37%)

01/13/21 Deutsche Bank
DaVita price target raised to $150 from $105 at Deutsche Bank
01/06/21 Argus
Humana price target raised to $450 from $430 at Argus
01/04/21
Fly Intel: Top five analyst upgrades
01/04/21
Humana upgraded to Outperform at RBC Capital on above-average MA growth
HUM Humana
$403.97 /

-1.5 (-0.37%)

HUM Humana
$403.97 /

-1.5 (-0.37%)

HUM Humana
$403.97 /

-1.5 (-0.37%)

Initiation
Good Natured Products initiated with an Outperform at Raymond James » 09:22
01/26/21
01/26
09:22
01/26/21
09:22
SLGBF

Good Natured Products

$0.00 /

+ (+0.00%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Hot Stocks
Johnson & Johnson sees no biosimilar entrants in Pharmaceutical segment in FY21  09:21
01/26/21
01/26
09:21
01/26/21
09:21
JNJ

Johnson & Johnson

$165.91 /

+2.23 (+1.36%)

 
ShowHide Related Items >><<
JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

01/15/21 B. Riley Securities
Arcturus Therapeutics downgraded to Neutral from Buy at B. Riley Securities
01/14/21 Morgan Stanley
80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley
01/14/21 Oppenheimer
Essa Pharma price target raised to $20 from $9 at Oppenheimer
12/29/20 Piper Sandler
Piper still believes in Arcturus vaccine after 'underwhelming' immunogenicity
JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

Recommendations
AMC Entertainment's capital raise results in massive dilution, says Loop Capital » 09:20
01/26/21
01/26
09:20
01/26/21
09:20
AMC

AMC Entertainment

/

+

Loop Capital analyst Alan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AMC AMC Entertainment
/

+

AMC AMC Entertainment
/

+

08:09 Today B. Riley Securities
AMC Entertainment price target raised to $5.50 from $3.50 at B. Riley Securities
12/28/20 B. Riley Securities
'Wonder Women' opens well above expectations, says B. Riley Securities
12/04/20 B. Riley Securities
Theater selloff on Warner Bros. news likely an overreaction, says B. Riley
11/03/20 B. Riley Securities
AMC Entertainment price target lowered to $3.50 from $4.50 at B. Riley Securities
AMC AMC Entertainment
/

+

AMC AMC Entertainment
/

+

AMC AMC Entertainment
/

+

AMC AMC Entertainment
/

+

Initiation
5N Plus initiated with a Strong Buy at Raymond James » 09:19
01/26/21
01/26
09:19
01/26/21
09:19
FPLSF

5N Plus

$0.00 /

+ (+0.00%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FPLSF 5N Plus
$0.00 /

+ (+0.00%)

01/13/21 National Bank
5N Plus price target raised to C$4 from C$2.90 at National Bank
Conference/Events
DIA to hold a virtual conference » 09:19
01/26/21
01/26
09:19
01/26/21
09:19
ABBV

AbbVie

$110.26 /

-0.6 (-0.54%)

, ALXN

Alexion

$161.30 /

+1.55 (+0.97%)

, AZN

AstraZeneca

$54.02 /

+0.76 (+1.43%)

, BIIB

Biogen

$275.38 /

+6.16 (+2.29%)

, BMY

Bristol-Myers

$64.82 /

+0.26 (+0.40%)

, ESALY

Eisai

$0.00 /

+ (+0.00%)

, HALO

Halozyme

$48.78 /

-0.73 (-1.47%)

, IQV

Iqvia

$182.87 /

-3.04 (-1.64%)

, LLY

Eli Lilly

$212.52 /

+6.22 (+3.02%)

, MSFT

Microsoft

$229.34 /

+3.45 (+1.53%)

Pharmacovigilance &…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ABBV AbbVie
$110.26 /

-0.6 (-0.54%)

ALXN Alexion
$161.30 /

+1.55 (+0.97%)

AZN AstraZeneca
$54.02 /

+0.76 (+1.43%)

BIIB Biogen
$275.38 /

+6.16 (+2.29%)

BMY Bristol-Myers
$64.82 /

+0.26 (+0.40%)

ESALY Eisai
$0.00 /

+ (+0.00%)

HALO Halozyme
$48.78 /

-0.73 (-1.47%)

IQV Iqvia
$182.87 /

-3.04 (-1.64%)

LLY Eli Lilly
$212.52 /

+6.22 (+3.02%)

MSFT Microsoft
$229.34 /

+3.45 (+1.53%)

ABBV AbbVie
$110.26 /

-0.6 (-0.54%)

01/06/21 RBC Capital
AbbVie named one of top stocks to own in 2021 by RBC Capital
12/17/20 Stifel
Outcome in Evolus IP case 'better than most investors expected,' says Stifel
12/16/20 SVB Leerink
AbbVie price target raised to $128 from $119 at SVB Leerink
12/15/20 Mizuho
AbbVie price target raised to $117 from $111 at Mizuho
ALXN Alexion
$161.30 /

+1.55 (+0.97%)

01/08/21 Raymond James
Alexion downgraded to Market Perform from Outperform at Raymond James
12/16/20 Truist
Alexion downgraded to Hold from Buy at Truist
12/15/20 Truist
Argenx price target raised to $350 from $275 at Truist
12/14/20 Citi
Alexion downgraded to Neutral from Buy at Citi
AZN AstraZeneca
$54.02 /

+0.76 (+1.43%)

01/22/21 Barclays
AstraZeneca price target lowered to 9,000 GBp from 9,300 GBp at Barclays
01/19/21 BTIG
Adaptive Biotechnologies price target raised to $74 from $66 at BTIG
01/15/21 Berenberg
AstraZeneca price target lowered to 10,000 GBp from 10,500 GBp at Berenberg
01/15/21
Fly Intel: Top five analyst initiations
BIIB Biogen
$275.38 /

+6.16 (+2.29%)

01/14/21 Truist
Truist says FDA wouldn't be discussing label if not going to approve aducanumab
01/11/21 Goldman Sachs
Eli Lilly's Alzheimer's trial data a 'positive surprise,' says Goldman Sachs
12/04/20 Mizuho
Sage Therapeutics upgraded to Buy from Neutral at Mizuho
12/01/20 Truist
Sage Therapeutics price target raised to $70 from $60 at Truist
BMY Bristol-Myers
$64.82 /

+0.26 (+0.40%)

01/20/21 William Blair
Exelixis selloff on competitive concerns an 'overreaction,' says William Blair
01/20/21 Citi
Citi opens 'negative Catalyst Watch' on Bristol-Myers
12/15/20 Goldman Sachs
Bristol-Myers upgraded to Conviction Buy from Buy at Goldman Sachs
12/09/20 Mizuho
Pentwater seeks to replace Bristol-Myers Squibb CVR trustee, says Mizuho
ESALY Eisai
$0.00 /

+ (+0.00%)

01/20/21 William Blair
Exelixis selloff on competitive concerns an 'overreaction,' says William Blair
11/05/20 Jefferies
Eisai upgraded to Buy from Hold at Jefferies
09/08/20 Jefferies
Eisai downgraded to Hold from Buy at Jefferies
HALO Halozyme
$48.78 /

-0.73 (-1.47%)

01/25/21 BMO Capital
Halozyme price target raised to $65 from $56 at BMO Capital
01/21/21 Benchmark
Halozyme price target raised to $59 from $46 at Benchmark
01/14/21 Piper Sandler
Halozyme price target raised to $50 from $42 at Piper Sandler
01/11/21 Benchmark
Phesgo EU approval/Horizon deal fuel Halozyme increased guidance, says Benchmark
IQV Iqvia
$182.87 /

-3.04 (-1.64%)

12/18/20 Mizuho
Iqvia price target raised to $200 from $190 at Mizuho
10/22/20 Deutsche Bank
Iqvia price target raised to $196 from $180 at Deutsche Bank
10/21/20 UBS
Iqvia price target raised to $224 from $204 at UBS
10/21/20 Morgan Stanley
Iqvia price target raised to $195 from $182 at Morgan Stanley
LLY Eli Lilly
$212.52 /

+6.22 (+3.02%)

01/20/21 Citi
Citi opens 'positive Catalyst Watch' on Eli Lilly into Alzheimer's data
01/19/21 Roth Capital
Merus price target raised to $32 from $19 at Roth Capital
01/19/21
Fly Intel: Top five analyst upgrades
01/19/21 Mizuho
Eli Lilly upgraded to Buy from Neutral at Mizuho
MSFT Microsoft
$229.34 /

+3.45 (+1.53%)

01/25/21 Raymond James
Microsoft assumed with a Strong Buy at Raymond James
01/25/21 Morgan Stanley
Morgan Stanley says market closer to recognizing Alphabet sum-of-the-parts value
01/25/21 DA Davidson
Box downgraded to Neutral from Buy at DA Davidson
01/22/21 RBC Capital
Varonis price target raised to $200 from $165 at RBC Capital
ABBV AbbVie
$110.26 /

-0.6 (-0.54%)

ALXN Alexion
$161.30 /

+1.55 (+0.97%)

AZN AstraZeneca
$54.02 /

+0.76 (+1.43%)

BIIB Biogen
$275.38 /

+6.16 (+2.29%)

BMY Bristol-Myers
$64.82 /

+0.26 (+0.40%)

HALO Halozyme
$48.78 /

-0.73 (-1.47%)

IQV Iqvia
$182.87 /

-3.04 (-1.64%)

LLY Eli Lilly
$212.52 /

+6.22 (+3.02%)

MSFT Microsoft
$229.34 /

+3.45 (+1.53%)

ABBV AbbVie
$110.26 /

-0.6 (-0.54%)

ALXN Alexion
$161.30 /

+1.55 (+0.97%)

AZN AstraZeneca
$54.02 /

+0.76 (+1.43%)

BIIB Biogen
$275.38 /

+6.16 (+2.29%)

BMY Bristol-Myers
$64.82 /

+0.26 (+0.40%)

LLY Eli Lilly
$212.52 /

+6.22 (+3.02%)

MSFT Microsoft
$229.34 /

+3.45 (+1.53%)

ABBV AbbVie
$110.26 /

-0.6 (-0.54%)

ALXN Alexion
$161.30 /

+1.55 (+0.97%)

AZN AstraZeneca
$54.02 /

+0.76 (+1.43%)

BIIB Biogen
$275.38 /

+6.16 (+2.29%)

BMY Bristol-Myers
$64.82 /

+0.26 (+0.40%)

ESALY Eisai
$0.00 /

+ (+0.00%)

HALO Halozyme
$48.78 /

-0.73 (-1.47%)

IQV Iqvia
$182.87 /

-3.04 (-1.64%)

LLY Eli Lilly
$212.52 /

+6.22 (+3.02%)

MSFT Microsoft
$229.34 /

+3.45 (+1.53%)

ALXN Alexion
$161.30 /

+1.55 (+0.97%)

BIIB Biogen
$275.38 /

+6.16 (+2.29%)

ABBV AbbVie
$110.26 /

-0.6 (-0.54%)

ALXN Alexion
$161.30 /

+1.55 (+0.97%)

AZN AstraZeneca
$54.02 /

+0.76 (+1.43%)

BIIB Biogen
$275.38 /

+6.16 (+2.29%)

BMY Bristol-Myers
$64.82 /

+0.26 (+0.40%)

LLY Eli Lilly
$212.52 /

+6.22 (+3.02%)

MSFT Microsoft
$229.34 /

+3.45 (+1.53%)

Hot Stocks
Draganfly's Vital Intelligence Technology selected by The 517 Group » 09:19
01/26/21
01/26
09:19
01/26/21
09:19
DFLYF

Draganfly

$0.00 /

+ (+0.00%)

Draganfly announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DFLYF Draganfly
$0.00 /

+ (+0.00%)

DFLYF Draganfly
$0.00 /

+ (+0.00%)

Hot Stocks
Seanergy joins 'Neptune Declaration on Seafarer Wellbeing and Crew Change' » 09:18
01/26/21
01/26
09:18
01/26/21
09:18
SHIP

Seanergy Marine

$1.20 /

+0.225 (+23.20%)

Seanergy Maritime…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SHIP Seanergy Marine
$1.20 /

+0.225 (+23.20%)

SHIP Seanergy Marine
$1.20 /

+0.225 (+23.20%)

07/08/20 Maxim
Seanergy Marine downgraded to Hold from Buy at Maxim
07/08/20 Maxim
Seanergy Marine downgraded to Hold from Buy at Maxim
SHIP Seanergy Marine
$1.20 /

+0.225 (+23.20%)

  • 18
    Aug

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.